Khalil Azizian

2.3k total citations
26 papers, 464 citations indexed

About

Khalil Azizian is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Khalil Azizian has authored 26 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Khalil Azizian's work include Reproductive tract infections research (6 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Khalil Azizian is often cited by papers focused on Reproductive tract infections research (6 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Khalil Azizian collaborates with scholars based in Iran, China and Iraq. Khalil Azizian's co-authors include Ansar Karimian, Mahmood Maniati, Sadra Samavarchi Tehrani, Maryam Abbastabar, Ebrahim Kouhsari, Bahman Yousefi, Maryam Majidinia, Mehdi Yousefi, Hadi Parsian and Vahid Shafiei‐Irannejad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Khalil Azizian

23 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalil Azizian Iran 10 260 69 60 56 43 26 464
Halei Sheng China 13 276 1.1× 45 0.7× 36 0.6× 37 0.7× 32 0.7× 16 436
Alireza Farasat Iran 14 351 1.4× 59 0.9× 44 0.7× 52 0.9× 25 0.6× 43 584
Kim M. Blakely Canada 10 203 0.8× 104 1.5× 110 1.8× 112 2.0× 30 0.7× 11 496
Shuangquan Yan China 12 128 0.5× 29 0.4× 65 1.1× 70 1.3× 28 0.7× 27 363
Nannan Song China 15 220 0.8× 34 0.5× 65 1.1× 69 1.2× 55 1.3× 42 604
Benjamin W. Casterline United States 7 285 1.1× 62 0.9× 88 1.5× 40 0.7× 19 0.4× 11 482
Zhen Zhu China 13 190 0.7× 28 0.4× 60 1.0× 22 0.4× 34 0.8× 39 413
Cristabelle De Souza United States 16 373 1.4× 127 1.8× 30 0.5× 84 1.5× 45 1.0× 39 721
Ching‐Shu Suen Taiwan 13 278 1.1× 68 1.0× 24 0.4× 88 1.6× 19 0.4× 22 492
Parul Mehra India 14 219 0.8× 70 1.0× 45 0.8× 66 1.2× 58 1.3× 23 505

Countries citing papers authored by Khalil Azizian

Since Specialization
Citations

This map shows the geographic impact of Khalil Azizian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Azizian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Azizian more than expected).

Fields of papers citing papers by Khalil Azizian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Azizian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Azizian. The network helps show where Khalil Azizian may publish in the future.

Co-authorship network of co-authors of Khalil Azizian

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Azizian. A scholar is included among the top collaborators of Khalil Azizian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Azizian. Khalil Azizian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chenfu, et al.. (2025). Global trends in antimicrobial resistance of Enterococcus faecium: a systematic review and meta-analysis of clinical isolates. Frontiers in Pharmacology. 16. 1505674–1505674. 4 indexed citations
2.
3.
Azizian, Khalil, et al.. (2025). Cell wall-inhibiting antibiotics resistance in Streptococcus pneumoniae causing invasive diseases: a global systematic review and meta-analysis in pediatric populations. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 51(1). 322–322.
4.
Wang, Yang, et al.. (2025). Global trends of ceftazidime–avibactam resistance in gram-negative bacteria: systematic review and meta-analysis. Antimicrobial Resistance and Infection Control. 14(1). 10–10. 8 indexed citations
5.
Hasani, Alka, Alka Hasani, Behzad Baradaran, et al.. (2024). Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal. Heliyon. 10(4). e26193–e26193. 2 indexed citations
6.
Sholeh, Mohammad, et al.. (2024). Corrigendum: Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis. Frontiers in Pharmacology. 15. 1465628–1465628. 3 indexed citations
7.
Sholeh, Mohammad, et al.. (2024). Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis. Frontiers in Pharmacology. 15. 1284665–1284665. 10 indexed citations
8.
Wu, Yaping, et al.. (2023). Trends of fluoroquinolones resistance in Mycoplasma and Ureaplasma urogenital isolates: Systematic review and meta-analysis. Journal of Global Antimicrobial Resistance. 36. 13–25. 9 indexed citations
9.
Yang, Yue, et al.. (2023). Tetracyclines resistance in Mycoplasma and Ureaplasma urogenital isolates derived from human: a systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials. 22(1). 83–83. 7 indexed citations
10.
Hasani, Alka, Behzad Baradaran, Jalal Abdolalizadeh, et al.. (2022). Chitosan nanoparticles containing fusion protein (Hspx–PPE44–EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis. Journal of Biomaterials Applications. 37(1). 40–47. 8 indexed citations
11.
Liu, Fei, et al.. (2022). Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials. 21(1). 37–37. 26 indexed citations
12.
Amani, Jafar, et al.. (2021). Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer. DNA repair. 102. 103103–103103. 25 indexed citations
13.
Ye, Mao, et al.. (2021). Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis. Annals of Clinical Microbiology and Antimicrobials. 20(1). 73–73. 21 indexed citations
14.
Babaie, Farhad, et al.. (2021). Emergence of azithromycin and third-generation cephalosporins resistant Shigella isolated from Iranian children. Gene Reports. 26. 101485–101485. 2 indexed citations
15.
Kouhsari, Ebrahim, et al.. (2020). Clinical, epidemiological, laboratory, and radiological characteristics of novel Coronavirus (2019-nCoV) in retrospective studies: A systemic review and meta-analysis. Indian Journal of Medical Microbiology. 39(1). 104–115. 9 indexed citations
16.
Karimian, Ansar, Forough Alemi, Zatollah Asemi, et al.. (2020). CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases. Life Sciences. 259. 118165–118165. 33 indexed citations
17.
Azizian, Khalil, et al.. (2020). The potential use of theranostic bacteria in cancer. Journal of Cellular Physiology. 236(6). 4184–4194. 9 indexed citations
18.
Moaddab, Seyed Yaghoub, et al.. (2019). Effects of 12-week treatment with Sovodak in patients infected by genotype 1 hepatitis C virus. 7(1). 1–6. 2 indexed citations
19.
20.
Mosavari, Nader, et al.. (2014). Molecular typing of Mycobacterium tuberculosis strains isolated from patients in Markazi Province. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Halei Sheng Breakdown of academic impact, for papers by Alireza Farasat Breakdown of academic impact, for papers by Kim M. Blakely Breakdown of academic impact, for papers by Shuangquan Yan Breakdown of academic impact, for papers by Nannan Song Breakdown of academic impact, for papers by Benjamin W. Casterline Breakdown of academic impact, for papers by Zhen Zhu Breakdown of academic impact, for papers by Cristabelle De Souza Breakdown of academic impact, for papers by Ching‐Shu Suen Breakdown of academic impact, for papers by Parul Mehra
Rankless by CCL
2026